Chemical and Pharmaceutical Bulletin p. 1858 - 1864 (1996)
Update date:2022-08-05
Topics:
Take, Kazuhiko
Okumura, Kazuo
Tsubaki, Kazunori
Taniguchi, Kiyoshi
Terai, Takao
Shiokawa, Youichi
N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine ((±)-3) was designed to restrict the conformation of terodiline I and was synthesized in a 6-step approach starting with diphenylacetaldehyde (10) or in a 4-step approach starting with 2,2-diphenyl-4-pentenoi
View MoreSHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551413
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong，Yuandong Road Fengxian District, Shanghai ,China
CHANGYI CITY FENGRUN FINE CHEMICAL CO.,LTD
website:http://www.fengrunhuagong.com
Contact:+86-536-7869976
Address:Changyi Coastal Economic Development Zone
Contact:13736652831
Address:NO.273 SHANGHAI SOUTH STREET,LUQIAO DISTRICT,ZHEJIANG PROVINCE,CHINA.
Shanghai AoBo Bio-Pharmaceutical Technology Co., Ltd.
Contact:+86-21-51320130-801, 816
Address:Room 601, No. 1011, Halei Road, Zhangjiang High-Tech Park, Pudong, Shanghai
Doi:10.1039/a806200e
(1998)Doi:10.1021/jo00926a009
(1974)Doi:10.1021/jo00926a028
(1974)Doi:10.1246/bcsj.50.3417
(1977)Doi:10.1021/jo00322a047
(1981)Doi:10.1016/S0022-328X(00)86537-7
(1973)
